Published in Neuropsychiatr Dis Treat on December 01, 2006
Irritable bowel syndrome. Nat Rev Dis Prim (2016) 1.14
Antidepressant use and diabetes mellitus risk: a meta-analysis. Korean J Fam Med (2013) 0.89
Antidepressants can treat inflammatory bowel disease through regulation of the nuclear factor-κB/nitric oxide pathway and inhibition of cytokine production: A hypothesis. World J Gastrointest Pharmacol Ther (2012) 0.80
Risk analysis of use of different classes of antidepressants on subsequent dementia: A nationwide cohort study in Taiwan. PLoS One (2017) 0.75
Usefulness of milnacipran in treating phantom limb pain. Neuropsychiatr Dis Treat (2012) 0.75
The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum (1990) 27.50
Descending control of pain. Prog Neurobiol (2002) 6.20
The fibromyalgia impact questionnaire: development and validation. J Rheumatol (1991) 5.94
Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci (1984) 4.87
Management of fibromyalgia. Ann Intern Med (1999) 4.54
Management of fibromyalgia syndrome. JAMA (2004) 4.47
Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum (2002) 3.99
A new view on hypocortisolism. Psychoneuroendocrinology (2005) 3.30
Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem (1994) 2.77
Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2005) 2.71
Peripheral and central contributions to hyperalgesia in irritable bowel syndrome. J Pain (2006) 2.65
Endogenous pain control mechanisms: review and hypothesis. Ann Neurol (1978) 2.63
Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain (2001) 2.62
Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med (1975) 2.57
A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum (2004) 2.48
A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med (2002) 2.34
Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl (2005) 2.28
Family study of fibromyalgia. Arthritis Rheum (2004) 2.22
Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum (1992) 2.18
A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain (2005) 2.10
Wind-up of spinal cord neurones and pain sensation: much ado about something? Prog Neurobiol (2000) 2.06
A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum (1996) 2.01
Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum (1993) 1.95
Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain (2003) 1.89
Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol (1992) 1.74
The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med (2002) 1.74
Emerging concepts in the neurobiology of chronic pain: evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc (1999) 1.74
Effects of noradrenergic and serotonergic antidepressants on chronic low back pain intensity. Pain (1999) 1.71
Classification, epidemiology, and natural history of fibromyalgia. Curr Pain Headache Rep (2001) 1.63
Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci (2006) 1.63
Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics (1999) 1.60
Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthritis Rheum (2002) 1.58
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol (1993) 1.54
Epidemiology of fibromyalgia. Curr Pain Headache Rep (2003) 1.50
The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol (2006) 1.50
A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum (1986) 1.48
Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) (2002) 1.47
Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics (2000) 1.45
Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum (1999) 1.31
Prevalence, comorbidity and impact of irritable bowel syndrome in Norway. Scand J Gastroenterol (2006) 1.31
Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum (1994) 1.28
Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum (1995) 1.28
Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol (2005) 1.26
Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol (1991) 1.26
Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum (2005) 1.23
Hypothalamic-pituitary-adrenal stress axis function and the relationship with chronic widespread pain and its antecedents. Arthritis Res Ther (2005) 1.18
Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum (1986) 1.18
Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med (2000) 1.17
Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum (2002) 1.17
Responsiveness of fibromyalgia clinical trial outcome measures. J Rheumatol (2000) 1.16
Alpha sleep characteristics in fibromyalgia. Arthritis Rheum (2001) 1.14
Treatment of fibromyalgia with cyclobenzaprine: A meta-analysis. Arthritis Rheum (2004) 1.13
Neuroendocrine perturbations in fibromyalgia and chronic fatigue syndrome. Rheum Dis Clin North Am (2000) 1.13
Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des (2006) 1.12
Hyperexcitability in fibromyalgia. J Rheumatol (1998) 1.12
An open clinical trial of venlafaxine treatment of fibromyalgia. Psychosomatics (1998) 1.06
Pain, disability, and pain/disability relationships in seven rheumatic disorders: a study of 1,522 patients. J Rheumatol (1991) 1.06
Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome. Rheumatology (Oxford) (2001) 1.04
Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol (2002) 1.03
A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum (1988) 1.03
A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain (1995) 1.02
Reboxetine: a norepinephrine selective reuptake pump inhibitor. J Psychiatr Pract (2004) 1.01
The projections of noradrenergic neurons in the A5 catecholamine cell group to the spinal cord in the rat: anatomical evidence that A5 neurons modulate nociception. Brain Res (1993) 1.01
Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Am J Med (1999) 1.01
Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review. Pain Med (2000) 1.01
A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder. Br J Rheumatol (1998) 1.00
A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res (2000) 0.98
Complementary and alternative medical therapies in fibromyalgia. Curr Pharm Des (2006) 0.98
A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol (1994) 0.98
Hypothalamic-pituitary-gonadal axis and cortisol in young women with primary fibromyalgia: the potential roles of depression, fatigue, and sleep disturbance in the occurrence of hypocortisolism. Ann Rheum Dis (2004) 0.97
Major depression, fibromyalgia and labour force participation: a population-based cross-sectional study. BMC Musculoskelet Disord (2006) 0.97
Citalopram in patients with fibromyalgia--a randomized, double-blind, placebo-controlled study. Eur J Pain (2000) 0.97
Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res (1998) 0.96
Norepinephrine-evoked pain in fibromyalgia. A randomized pilot study [ISRCTN70707830]. BMC Musculoskelet Disord (2002) 0.95
Clinical experience with dual action antidepressants in different chronic pain syndromes. Hum Psychopharmacol (2004) 0.95
Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry (1985) 0.94
Fibromyalgia: present to future. Curr Rheumatol Rep (2005) 0.94
Neurohormonal perturbations in fibromyalgia. Baillieres Clin Rheumatol (1996) 0.93
The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am (1996) 0.93
Venlafaxine treatment of fibromyalgia. Ann Pharmacother (2003) 0.91
The analgesic effect of tricyclic antidepressants. Brain Res (1990) 0.89
Fibromyalgia--from syndrome to disease. Overview of pathogenetic mechanisms. J Rehabil Med (2003) 0.85
Evaluation of reboxetine, a noradrenergic antidepressant, for the treatment of fibromyalgia and chronic low back pain. Psychosomatics (2005) 0.85
The management of fibromyalgia. Drugs Today (Barc) (2004) 0.85
Fibromyalgia syndrome and serotonin. Clin Exp Rheumatol (2001) 0.84
Open trial of mirtazapine in patients with fibromyalgia. Pharmacopsychiatry (2004) 0.83
Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol Suppl (1989) 0.83
Rational and targeted pharmacologic treatment of fibromyalgia. Rheum Dis Clin North Am (2002) 0.82
Mirtazapine: a review of its clinical efficacy and tolerability. Expert Opin Pharmacother (2005) 0.82
The hypothalamic-pituitary-adrenal stress axis in fibromyalgia and chronic fatigue syndrome. Z Rheumatol (1998) 0.82
Effect of p-chlorophenylalanine and alpha-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol Toxicol (1995) 0.82
Current trends in neuropathic pain treatments with special reference to fibromyalgia. CNS Spectr (2005) 0.81
[Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia]. Minerva Med (1994) 0.81
Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J Rheumatol (1992) 0.81
[A comparative study of fibromyalgia treatment: ultrasonography and physiotherapy versus sertraline treatment]. Ann Readapt Med Phys (2005) 0.81
Is fibromyalgia a neurologic disease? Curr Pain Headache Rep (2002) 0.80
The psychopharmacology of fibromyalgia: a drug development perspective. Psychopharmacol Bull (2002) 0.80
Genetic factors in neuromuscular pain. CNS Spectr (2005) 0.80
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr (2005) 2.71
The increasing burden of depression. Neuropsychiatr Dis Treat (2011) 2.09
The epidemiology of pain in depression. Hum Psychopharmacol (2004) 1.43
Understanding pain in depression. Hum Psychopharmacol (2004) 1.02
The importance of norepinephrine in depression. Neuropsychiatr Dis Treat (2011) 0.96
Sedation, an unpleasant, undesirable and potentially dangerous side-effect of many psychotropic drugs. Hum Psychopharmacol (2004) 0.83
Drugs to treat fibromyalgia - the transatlantic difference. Curr Opin Investig Drugs (2010) 0.82
Noradrenergic symptom cluster in depression. Neuropsychiatr Dis Treat (2011) 0.80
The noradrenergic symptom cluster: clinical expression and neuropharmacology. Neuropsychiatr Dis Treat (2011) 0.79
Resolution of sexual dysfunction during acute treatment of major depression with milnacipran. Hum Psychopharmacol (2008) 0.77
Fibromyalgia: a complex syndrome requiring a multidisciplinary approach. Hum Psychopharmacol (2009) 0.77
The management of depression: An international naturalistic survey. Int J Psychiatry Clin Pract (2008) 0.76
Japanese experience with milnacipran, the first serotonin and norepinephrine reuptake inhibitor in Japan. Neuropsychiatr Dis Treat (2007) 0.75
Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia? Hum Psychopharmacol (2009) 0.75